Physician profile
Mahnaz Mostofi
NPI 1457722407
$2,228.44
in general payments reported to CMS, 2019-2025
17 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Women'S Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $292 · 2022: $1,133 · 2023: $572 · 2024: $61.66 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $923.53 | 2022 | |
| Abbvie INC. | $258.86 | 2021-2023 | |
| Viiv Healthcare Company | $254.99 | 2023 | Apretude |
| Mayne Pharma Commercial LLC | $155.67 | 2021-2025 | |
| Exeltis, USA INC. | $131.00 | 2023 | Slynd |
| Astellas Pharma US INC | $97.43 | 2023 | Veozah |
| Cumberland Pharmaceuticals, INC. | $97.07 | 2022 | |
| Mylan Pharmaceuticals INC. | $54.23 | 2021-2022 | |
| Organon LLC | $50.01 | 2021-2025 | Nexplanon |
| Pfizer INC. | $37.10 | 2023 | |
| Sumitomo Pharma America, INC. | $32.32 | 2023 | Myfembree |
| Myovant Sciences INC. | $30.63 | 2021-2022 | |
| Exact Sciences Corporation | $27.82 | 2025 | Cologuard Collection Kit |
| Axonics, INC. | $24.22 | 2024 | Bulkamid |
| Evofem Biosciences, INC. | $19.05 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $17.67 | 2024 | Intrarosa |
| Minerva Surgical, INC | $16.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahnaz Mostofi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.